It has been proved that both IFN-γ and IL-4 can effectively upregulate the expression of PD-L2 in either immune cells or cancer cells [16–18], so we further examined the effects of both IFN-γ and IL-4 on PD-L2 secretion of tumor cells. The gene discussed is IFNG; the disease is neoplasm.